Published in

Elsevier, Journal of Hepatology, 3(78), p. 513-523, 2023

DOI: 10.1016/j.jhep.2022.09.027

Links

Tools

Export citation

Search in Google Scholar

Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO